朗格汉斯细胞组织细胞增生症患儿的远期结局
该回顾性研究纳入70例朗格汉斯细胞组织细胞增生症(LCH)患儿,平均观察12年,发现56%存在LCH相关后遗症,多系统疾病及复发者更常见;复发累积发生率为34%,多数发生在诊断后2.5年内;神经系统后遗症可在初诊10年后出现,需长期 vigilant 随访。
要点
- LCH患儿56%存在后遗症,多系统疾病和复发者更常见。
- 复发累积发生率34%,多数发生在诊断后2.5年内。
- 神经系统后遗症可迟至初诊10年后出现,需长期随访。
核心结论
- LCH后遗症常见,部分较轻微,但神经系统后遗症可能特别严重且致残。
- 需警惕长期后遗症,尤其是多系统疾病、复发及有CNS风险病变者。
研究设计与样本
- 单中心回顾性研究,纳入70例在该中心诊治的LCH患者,回顾病历资料。
- 平均观察时间12年(中位数10.7年,范围1-31.3年)。
主要发现
- 56%(n=39)存在LCH相关后遗症,多系统疾病和复发患者中更常见。
- 后遗症患病率:骨科相关27%、尿崩症19%、生长迟缓13%、容貌相关10%、神经7%、听力7%、垂体前叶激素缺乏7%、肝胆4%、眼科3%。
- 复发累积发生率为34%,多数复发发生在诊断后2.5年内。
- 神经系统后遗症可在LCH初诊后10年才出现。
- 复发、存在中枢神经系统(CNS)风险病变及接受放疗与更高后遗症发生率相关。
临床怎么用
- 对LCH患儿应进行警惕的长期随访,以优化结局。
- 关注多系统疾病、复发及有CNS风险病变患儿的后遗症筛查。
局限性
- 回顾性研究设计,样本量70例,来自单中心。
- 原文未报告失访率、具体后遗症评估方法及多因素分析结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Langerhans cell histiocytosis (LCH) is a rare disease with diverse clinical courses. Despite improvement in survival outcomes in the recent decades, sequelae of the disease remain a concern. This study aimed to provide information on the long-term outcomes in patients with LCH, particularly on the sequelae and any associated factors. METHOD: Medical records of patients with diagnosis of LCH and being managed in our centre were retrospectively reviewed. Data on the courses of illness, mortality, intervention, types and time of late events were collected and analysed. RESULTS: 70 patients were included with a mean observation time of 12 years (median 10.7 years, range 1-31.3 years). Sequelae related to LCH were present in 56% (n=39), being more common in multisystem diseases and patients with reactivations. Prevalence of sequelae is as follows: orthopaedic related 27%, diabetes insipidus 19%, growth retardation 13%, cosmetic 10%, neurological 7%, hearing 7%, anterior pituitary hormone deficiency 7%, hepatobiliary 4% and ophthalmological 3%. Neurological sequelae could manifest even 10 years after initial diagnosis of LCH. Reactivations, presence of central nervous system (CNS) risk lesions and treatment with radiotherapy were associated with a higher rate of sequelae. The cumulative incidence of reactivation was 34%. Most reactivations occurred in the first 2.5 years after diagnosis. CONCLUSION: Sequelae were common after LCH, although some were mild. Neurological sequelae could be particularly severe and debilitating. Vigilant long-term follow-up would be essential for optimising patient outcomes. Further studies on the prevention and treatment of CNS disease of LCH are warranted.
引用
- Chow TW, Leung WK, Cheng FWT, et al. Late outcomes in children with Langerhans cell histiocytosis. Arch Dis Child. 2017. PMID: 28442470. doi:10.1136/archdischild-2016-312185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。